Briefly describe one voltage-gated ion channel and two protein pumps found in the heart. In your answer, you should explain how the voltage-gated ion channel responds to voltage changes and how it controls which ions pass through the channel. For the protein pumps, be sure to describe the structure of the protein pump and any conformational changes that it goes through. Additionally, you should briefly explain the importance of each ion channel or pump for the normal functioning of the cardiac muscle.

Briefly describe one voltage-gated ion channel and two protein pumps found in the heart. In your answer, you should explain how the voltage-gated ion channel responds to voltage changes and how it controls which ions pass through the channel. For the protein pumps, be sure to describe the structure of the protein pump and any conformational changes that it goes through. Additionally, you should briefly explain the importance of each ion channel or pump for the normal functioning of the cardiac muscle.

Biomedical Instrumentation Systems

1st Edition

ISBN:9781133478294

Author:Chatterjee

Publisher:Chatterjee

Chapter13: Artifacts And Noise In Medical Instrumentation

Section: Chapter Questions

Problem 1CS

See similar textbooks

Similar questions

The contracting cells of the heart are a type of striated muscle that is said to work as a functional syncytium. Provide a definition for “functional syncytium” and describe important functional characteristics and cellular specializations
Select the TRUE statement/s: Calcium channel blocker will affect which phase/s of the cardiac muscle cell action potential? Copyright © McGraw-Hill Education. Permission required for reproduction or display. +30- Membrane potential (mv) +10. -10- -30- -50- -70- -90 0 O A) Phase 1 OB) Phase 2 OC) Phase 3 (b) Electrical events at the sarcolemma of a cardiac muscle cell OD) Phase 4 3 0.15 Time (seconds) OE) All of the above RMP 0.30
The pressure in the aorta changes throughout the cardiac cycle. During systole, as the heart contracts, the outflux of blood into the aorta causes an increase in pressure, whereas during diastole the pressure decreases as the heart relaxes. A simple model for the aortic pressure waveform is given by the Windkessel effect described by the image below. In this model, the heart is considered a pressure generating pump which is directly connected to an elastic compartment (the aorta), which in turn is connected to a rigid set of peripheral vessels (the hose of the firefighter). 5 Pump Heart Air Windkessel Elastic arteries In order to find the aortic pressure waveform from the Windkessel model, a mass balance formulation around the aorta must be formulated. Coming into the aorta from the heart we have the flowrate Q(t). According to conservation of mass, this inflow rate Q(t) must be equal to the outflow rate into the peripheral vessels and the change in volume of the aorta. To find these…
In a sheet of ventricular cardiac muscle tissue, we should be able to observe electricity spreading between adjacent muscle cells (TRUE or FALSE) and from Purkinje fibers to muscle cells (TRUE or FALSE) via electrical synapses that form between the cell membranes.
You’ve conducted tensile testing of the aorta and constituent proteins with the results show below. Estimate the modulus of elasticity for (A) collagen and (B) elastin. (C)Discuss how the properties of each extracellular protein contributes to the mechanical behavior of the aorta at high and low strain.
Electrophoretic flow and electroosmotic flow (EOF) plays an important role in capillary electrophoresis (CE) for ions movement. Explain the differences between electrophoretic flow and EOF. b) Suggest two different approaches (other than reducing the voltage) to reduce the electroosmotic flow. c) Three water soluble vitamins: niacinamide (a neutral compound), riboflavin (a neutral compound) and thiamine (a cation) were separated by micellar electrokinetic capillary chromatography (MEKC) in 15 mM borate buffer (pH 8) with 50 mM sodium dodecyl sulfate. The migration times were niacinamide (7.5 min), riboflavin (12.8 min) and thiamine (13.9 min) Explain why these vitamins were separated using MEKC. Explain why niacinamide and riboflavin (both are neutral compounds) have different migration times. (i) With the aid of a diagram, differentiate flow profile of electroosmotic flow (EOF) and laminar flow. (ii) Discuss the effect of both flows in term of peak resolution.
A 65-year old man with heart failure is unable to climb a flight of stairs without experiencing dyspnea. After several years of therapy with carvedilol, captopril and furosemide, the therapeutic plan probably needs to change now. You empirically add digoxin to improve cardiac muscle contractility. Within 4 week he has a marked improvement in his symptoms. Which of the following best describes the main cellular action of digoxin that accounts for its ability to improve his cardiovascular function? Activates beta1-adrenergic receptors Facilitates GTP binding to specific proteins Increases mitochondrial calcium (Ca++) release Inhibits sarcolemmal Na/K-ATP-ase
Vascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions What is the advantage of measuring autophosphorylation of the receptor rather than phosphorylation of the substrate?
Vascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions How would you apply a TR-FRET assay to measure the in vitro kinase activity of VEGFR-2? Describe in steps the assay design and potential readout outcome.
Vascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions How would you determine robustness of the assay and validate the assay?
Vascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions While setting up your experiment, you accidentally discovered autophophorylation of receptor. What observation/results led you to believe that there was autophosphorylation of the receptor?
Vascular endothelial growth factor receptor 2 (VEGFR-2) is an endothelial cell-specific receptor that has inherent tyrosine kinase activity. The binding of the Vascular endothelial growth factor (VEGF) ligand to its receptor plays an important role in angiogenesis, a process by which new capillaries are formed. Enhanced angiogenesis is associated with a number of diseases including cancer. Your goal is to develop a homogeneous in vitro TR-FRET kinase assay for VEGFR-2 (purified protein) in an attempt to identify small molecules that inhibit kinase activity and in turn modulate angiogenesis. Based on this background, please answer the following questions If you wanted to measure the kinase activity of VEGFR-2, what are some of the conventional methods/assays you would use?